Selective Immunosuppressants: Janus Kinase Inhibitors (Upadacitinib)
Supply of medicinal products: Regular deliveries of medicinal products containing the active substance Upadacitinib (ATC L04AF03) for the treatment of patients in approved indications according to the Summary of Product Characteristics (SPC) valid on the date of tender submission.
CONTRACTING AUTHORITY
Name
Institut klinické a experimentální medicíny
City
Praha
Country
CZ
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33652300, Immunosuppressive agents.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
Yes
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
30 days remaining(LOT-0001)
Published